Published in Pediatr Nephrol on April 01, 1993
Dialysis-associated peritonitis in children. Pediatr Nephrol (2009) 1.35
Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update. Perit Dial Int (2012) 1.28
Experimental, clinical and preventive aspects of ototoxicity. Eur Arch Otorhinolaryngol (1994) 0.93
Strategies for the preservation of residual renal function in pediatric dialysis patients. Pediatr Nephrol (2013) 0.75
Network motifs: simple building blocks of complex networks. Science (2002) 35.80
Home monitoring of uterine activity. Does it prevent prematurity? N Engl J Med (1991) 17.76
Structure and function of the feed-forward loop network motif. Proc Natl Acad Sci U S A (2003) 12.50
Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet (2011) 10.73
floricaula: a homeotic gene required for flower development in antirrhinum majus. Cell (1990) 6.52
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Dynamic proteomics of individual cancer cells in response to a drug. Science (2008) 5.43
The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks. J Mol Biol (2003) 5.20
Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J Cell Biol (2001) 5.05
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
FCA, a gene controlling flowering time in Arabidopsis, encodes a protein containing RNA-binding domains. Cell (1997) 4.79
Effects of a decision support system on the diagnostic accuracy of users: a preliminary report. J Am Med Inform Assoc (1997) 4.61
Multiple independent defective suppressor-mutator transposon insertions in Arabidopsis: a tool for functional genomics. Plant Cell (1999) 4.57
Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J (1987) 4.56
Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res (2001) 4.50
Detailed map of a cis-regulatory input function. Proc Natl Acad Sci U S A (2003) 4.30
Genetic definition and sequence analysis of Arabidopsis centromeres. Science (1999) 4.20
Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science (1998) 4.07
Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature (1985) 3.97
Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol (1998) 3.86
Evolutionary trade-offs, Pareto optimality, and the geometry of phenotype space. Science (2012) 3.79
Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci U S A (2000) 3.74
Ordering genes in a flagella pathway by analysis of expression kinetics from living bacteria. Science (2001) 3.69
Biochemical characterization of human collagenase-3. J Biol Chem (1996) 3.52
Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. Biosynthesis, isolation, characterization, and substrates. J Biol Chem (1985) 3.51
Comparison of human stromelysin and collagenase by cloning and sequence analysis. Biochem J (1986) 3.31
Efficient sampling algorithm for estimating subgraph concentrations and detecting network motifs. Bioinformatics (2004) 3.25
The incoherent feed-forward loop accelerates the response-time of the gal system of Escherichia coli. J Mol Biol (2005) 3.13
TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett (1998) 3.04
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem (1996) 3.00
Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem (2001) 2.91
A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett (1992) 2.88
The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem (1998) 2.71
Subgraphs in random networks. Phys Rev E Stat Nonlin Soft Matter Phys (2003) 2.65
The impact of extreme prematurity and congenital anomalies on the interpretation of international comparisons of infant mortality. Obstet Gynecol (1995) 2.65
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Conservation of microstructure between a sequenced region of the genome of rice and multiple segments of the genome of Arabidopsis thaliana. Genome Res (2001) 2.56
Molecular characterization and regulation of the rhizosphere-expressed genes rhiABCR that can influence nodulation by Rhizobium leguminosarum biovar viciae. J Bacteriol (1992) 2.55
Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A (1991) 2.53
The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem (1996) 2.45
Airborne spread of measles in a suburban elementary school. Am J Epidemiol (1978) 2.37
Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol (2000) 2.33
Evidence that latent collagenases are enzyme-inhibitor complexes. Biochem J (1977) 2.32
Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer (1999) 2.31
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3. Invest Ophthalmol Vis Sci (1997) 2.28
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet (1989) 2.25
The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry (2010) 2.23
Purification and characterization of a rabbit bone metalloproteinase that degrades proteoglycan and other connective-tissue components. Biochem J (1983) 2.17
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen (2000) 2.15
Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. Proc Natl Acad Sci U S A (1998) 2.13
Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem (2000) 2.12
Purification of rabbit bone inhibitor of collagenase. Biochem J (1981) 2.12
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem (1997) 2.09
Nurse staffing and patient outcomes. Nurs Res (1998) 2.09
Relationship between x-ray exposure and malignant transformation in C3H 10T1/2 cells. Proc Natl Acad Sci U S A (1980) 2.08
Diagnosis and initial management of blunt pancreatic trauma: guidelines from a multiinstitutional review. Ann Surg (1998) 2.07
British HIV Association guidelines for the routine investigation and monitoring of adult HIV-1-infected individuals 2011. HIV Med (2012) 2.05
The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett (2000) 2.03
Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett (1996) 1.97
Human dendritic cells as targets of dengue virus infection. J Investig Dermatol Symp Proc (2001) 1.96
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis (1997) 1.92
Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology (1996) 1.91
ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochem Biophys Res Commun (2000) 1.90
Biosynthesis of tissue inhibitor of metalloproteinases by human fibroblasts in culture. Stimulation by 12-O-tetradecanoylphorbol 13-acetate and interleukin 1 in parallel with collagenase. J Biol Chem (1985) 1.86
The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem (1992) 1.85
The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol (1996) 1.82
Ultrasound findings in juvenile nephronophthisis. Pediatr Nephrol (1996) 1.82
Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genes. J Exp Med (1997) 1.81
The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis (1990) 1.80
Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect (2004) 1.79
Topological generalizations of network motifs. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 1.78
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology (1998) 1.75
Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci (1985) 1.73
Missed opportunities for diagnosing primary HIV infection. Sex Transm Infect (2007) 1.72
The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor. Biochem J (1983) 1.72
Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest (2001) 1.71
The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem (1995) 1.70
Partial purification of collagenase and gelatinase from human polymorphonuclear leucocytes. Analysis of their actions on soluble and insoluble collagens. Biochem J (1982) 1.66
Implications for HIV testing policy derived from combining data on voluntary confidential testing with viral sequences and serological analyses. Sex Transm Infect (2008) 1.66
Assessment and interpretation of the tubular threshold for phosphate in infants and children. Pediatr Nephrol (1994) 1.66
Human immunodeficiency virus (HIV) antibody avidity testing to identify recent infection in newly diagnosed HIV type 1 (HIV-1)-seropositive persons infected with diverse HIV-1 subtypes. J Clin Microbiol (2006) 1.64
The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes. Biochem J (1980) 1.64
Metalloproteinases from rabbit bone culture medium degrade types IV and V collagens, laminin and fibronectin. Biochem J (1981) 1.62
Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver. J Clin Invest (1992) 1.62
Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer (1999) 1.61
Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet. J Neurol Neurosurg Psychiatry (2009) 1.60
The National Cancer Data Base report on prostate cancer. Cancer (1994) 1.60
Acceptance and perceptions of NORPLANT among users in San Francisco, USA. Stud Fam Plann (1990) 1.60
Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect (1985) 1.60
The detection and characterisation of collagenase inhibitors from rabbit tissues in culture. Biochim Biophys Acta (1977) 1.57
Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta (1985) 1.56
Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem (1991) 1.55
Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J Biol Chem (1996) 1.55
Collagenase is a component of the specific granules of human neutrophil leucocytes. Biochem J (1977) 1.55
Hypercalciuria in the frequency-dysuria syndrome of childhood. J Pediatr (1990) 1.55
Creatinine for estimation of glomerular filtration rate. Pediatr Nephrol (1992) 1.53
An inhibitor of collagenase from human amniotic fluid. Purification, characterization and action on metalloproteinases. Biochem J (1981) 1.52
A cross-site vascular radiology on-call service: the Manchester experience. Clin Radiol (2005) 1.51